| [1] | Hillen LM, Vandyck H, Leunissen D, et al. Integrative histopathological and immunophenotypical characterisation of the inflammatory microenvironment in spitzoid melanocytic neoplasms[J]. Histopathology, 2021,78(4):607⁃626. doi: 10.1111/his.14259. | 
																													
																							| [2] | Wiesner T, He J, Yelensky R, et al. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas[J]. Nat Commun, 2014,5:3116. doi: 10.1038/ncomms4116. | 
																													
																							| [3] | Quan VL, Zhang B, Zhang Y, et al. Integrating next⁃generation sequencing with morphology improves prognostic and biologic classification of Spitz neoplasms[J]. J Invest Dermatol, 2020,140(8):1599⁃1608. doi: 10.1016/j.jid.2019.12.031. | 
																													
																							| [4] | de la Fouchardière A, Tee MK, Peternel S, et al. Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes[J]. Mod Pathol, 2021,34(4):735⁃747. doi: 10.1038/s41379⁃020⁃00678⁃6. | 
																													
																							| [5] | Bahrani E, Kunder CA, Teng JM, et al. Spitz nevus with EHBP1⁃ALK fusion and distinctive membranous localization of ALK[J]. J Cutan Pathol, 2022,49(6):584⁃588. doi: 10.1111/cup.14209. | 
																													
																							| [6] | Kiuru M, Jungbluth A, Kutzner H, et al. Spitz tumors: comparison of histological features in relationship to immunohistochemical staining for ALK and NTRK1[J]. Int J Surg Pathol, 2016,24(3):200⁃206. doi: 10.1177/10668969166 30375. | 
																													
																							| [7] | Kervarrec T, Pissaloux D, Tirode F, et al. Morphologic features in a series of 352 Spitz melanocytic proliferations help predict their oncogenic drivers[J]. Virchows Arch, 2022,480(2):369⁃382. doi: 10.1007/s00428⁃021⁃03227⁃x. | 
																													
																							| [8] | Urso C. Melanocytic Skin neoplasms: what lesson from genomic aberrations?[J]. Am J Dermatopathol, 2019,41(9):623⁃629. doi: 10.1097/DAD.0000000000001341. | 
																													
																							| [9] | Shain AH, Yeh I, Kovalyshyn I, et al. The genetic evolution of melanoma from precursor lesions[J]. N Engl J Med, 2015,373(20):1926⁃1936. doi: 10.1056/NEJMoa1502583. | 
																													
																							| [10] | van Dijk MC, Bernsen MR, Ruiter DJ. Analysis of mutations in B⁃RAF, N⁃RAS, and H⁃RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma[J]. Am J Surg Pathol, 2005,29(9):1145⁃1151. doi: 10.1097/01.pas.0000157749.18591.9e. | 
																													
																							| [11] | Elder DE, Massi D, Scolyer RA, et al. World Health Organization. WHO Classification of Skin Tumours[M]. 4th ed. France: Lyon, 2018:470. | 
																													
																							| [12] | 刘芳, 王江潮, 刘宇, 等. Spitz样肿瘤320例临床及组织病理分析[J]. 中华皮肤科杂志, 2021,54(1):33⁃41. doi: 10.35541/cjd.20200927. | 
																													
																							| [13] | 曹妍, 林秉奖, 郭盛华, 等. 结缔组织增生性Spitz痣一例[J]. 中华皮肤科杂志, 2020,53(2):142⁃143. doi: 10.35541/cjd.2019 0055. | 
																													
																							| [14] | 王逸飞, 宋昊, 耿怡, 等. 血管瘤样Spitz痣一例[J]. 中华皮肤科杂志, 2021,54(10):908⁃909. doi: 10.35541/cjd.20200038. | 
																													
																							| [15] | Rand AJ, Flejter WL, Dowling CA, et al. Atypical ALK⁃positive Spitz tumors with 9p21 homozygous deletion: report of two cases and review of the literature[J]. J Cutan Pathol, 2018,45(2):136⁃140. doi: 10.1111/cup.13057. | 
																													
																							| [16] | Gerami P, Kim D, Compres EV, et al. Clinical, morphologic, and genomic findings in ROS1 fusion Spitz neoplasms[J]. Mod Pathol, 2021,34(2):348⁃357. doi: 10.1038/s41379⁃020⁃00658⁃w. | 
																													
																							| [17] | Donati M, Kastnerova L, Martinek P, et al. Spitz tumors with ROS1 fusions: a clinicopathological study of 6 cases, including FISH for chromosomal copy number alterations and mutation analysis using next⁃generation sequencing[J]. Am J Dermatopathol, 2020,42(2):92⁃102. doi: 10.1097/DAD.0000000 000001499. | 
																													
																							| [18] | Cesinaro AM, Gallo G, Manfredini S, et al. ROS1 pattern of immunostaining in 11 cases of spitzoid tumour: comparison with histopathological, fluorescence in⁃situ hybridisation and next⁃generation sequencing analysis[J]. Histopathology, 2021,79(6):966⁃974. doi: 10.1111/his.14445. | 
																													
																							| [19] | Šekoranja D, Pižem J, Luzar B. An update on molecular genetic aberrations in Spitz melanocytic proliferations: correlation with morphological features and biological behavior[J]. Acta Med Acad, 2021,50(1):157⁃174. doi: 10.5644/ama2006⁃124.333. | 
																													
																							| [20] | Amin SM, Haugh AM, Lee CY, et al. A comparison of morphologic and molecular features of BRAF, ALK, and NTRK1 fusion spitzoid neoplasms[J]. Am J Surg Pathol, 2017,41(4):491⁃498. doi: 10.1097/PAS.0000000000000761. | 
																													
																							| [21] | Yeh I, Busam KJ, McCalmont TH, et al. Filigree⁃like rete ridges, lobulated nests, rosette⁃like structures, and exaggerated maturation characterize Spitz tumors with NTRK1 fusion[J]. Am J Surg Pathol, 2019,43(6):737⁃746. doi: 10.1097/PAS.000000 0000001235. | 
																													
																							| [22] | Saraggi D, Salmaso R, Zamuner C, et al. Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions[J]. J Am Acad Dermatol, 2018,79(4):728⁃735. doi: 10.1016/j.jaad. 2018.06.018. | 
																													
																							| [23] | Cappellesso R, Nozzoli F, Zito Marino F, et al. NTRK gene fusion detection in atypical Spitz tumors[J]. Int J Mol Sci, 2021,22(22):12332. doi: 10.3390/ijms222212332. | 
																													
																							| [24] | Moura MS, Costa J, Velasco V, et al. Pan⁃TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls[J]. Histopathology, 2024,84(3):451⁃462. doi: 10.1111/his.15082. | 
																													
																							| [25] | Fielder T, Butler J, Tierney G, et al. ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1[J]. Pathology, 2022,54(4):399⁃403. doi: 10.1016/j.pathol.2021.07.012. |